Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients
Atıf İçin Kopyala
ULUSOY C. A.
29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Danimarka, ss.450
-
Yayın Türü:
Bildiri / Tam Metin Bildiri
-
Basıldığı Ülke:
Danimarka
-
Sayfa Sayıları:
ss.450
-
İstanbul Üniversitesi Adresli:
Evet